GNLX Genelux
WatchlistGenelux News
Genelux(GNLX.US) Officer Sells US$436K in Common Stocks
$Genelux(GNLX.US)$ Officer Yu Yong sold 36,800 shares of Common Stocks on Dec 7, 2023 at an average price of $11.8477 for a total value of $436K.Source: Announcement What is statement of changes in be
Genelux Insider Sold Shares Worth $435,995, According to a Recent SEC Filing
Yong Yu, Vice President, Clinical Trial Operations, on December 07, 2023, sold 36,800 shares in Genelux (GNLX) for $435,995. Following the Form 4 filing with the SEC, Yu has control over a total of 32
THOR Industries Reports Upbeat Earnings, Joins Dave & Buster's Entertainment, Campbell Soup And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded higher, with the Dow Jones index gaining more than 50 points on Wednesday. Shares of THOR Industries, Inc. (NYSE:THO) shares moved higher during Wednesday's session following better
HC Wainwright Starts Genelux at Buy, Cites Olvi-Vec Potential
Genelux Gets Fast Track Status for Olvi-Vec in Ovarian Cancer
HC Wainwright & Co. Initiates Coverage On Genelux With Buy Rating, Announces Price Target of $35
HC Wainwright & Co. analyst Emily Bodnar initiates coverage on Genelux (NASDAQ:GNLX) with a Buy rating and announces Price Target of $35.
Genelux Corporation Receives FDA Fast Track Designation for Olvi-Vec in Platinum Resistant/Refractory Ovarian Cancer
- Pivotal Phase 3 Study of Olvi-Vec in Platinum Resistant/Refractory Ovarian Cancer Initiated in September 2022 - - Phase 2 Trial of Olvi-Vec- Demonstrated Clinical Reversal of Platinum Resistance and Refractoriness and
Analysts Are Bullish on These Healthcare Stocks: Genelux Corp. (GNLX), Calliditas Therapeutics (CALT)
Genelux Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 11/24/2023 170.39% Benchmark $38 → $30 Maintains Speculative Buy 09/12/2023 260.52% Maxim Group → $40 Init
Benchmark Company Adjusts Genelux Price Target to $30 From $38, Maintains Speculative Buy Rating
Benchmark Company Adjusts Genelux Price Target to $30 From $38, Maintains Speculative Buy Rating
Genelux(GNLX.US) Officer Sells US$191.56K in Common Stocks
$Genelux(GNLX.US)$ Officer Yu Yong sold 18,665 shares of Common Stocks on Nov 21, 2023 at an average price of $10.2628 for a total value of $191.56K.Source: Announcement What is statement of changes i
Genelux(GNLX.US) Officer Sells US$210.43K in Common Stocks
$Genelux(GNLX.US)$ Officer Yu Yong sold 18,135 shares of Common Stocks on Nov 17, 20, 2023 at an average price of $11.6036 for a total value of $210.43K.Source: Announcement What is statement of chang
Chegg, Perdoceo Education And Other Big Stocks Moving Lower On Monday
U.S. stocks traded higher, with the Dow Jones gaining over 50 points on Monday. Here are some big stocks recording losses in today's session. Yatsen Holding Limited (NYSE:YSG) shares tumbled 24.2% to
Retail Investors Invested in Genelux Corporation (NASDAQ:GNLX) Copped the Brunt of Last Week's US$51m Market Cap Decline
Key Insights Significant control over Genelux by retail investors implies that the general public has more power to influence management and governance-related decisions A total of 25 investors have
Genelux GAAP EPS of -$0.20 Misses by $0.02
Genelux 10% Owner Aladar Szalay Discloses Sale of 5,704 Shares
12 Health Care Stocks Moving In Friday's Intraday Session
GainersApollomics (NASDAQ:APLM) stock rose 66.2% to $0.94 during Friday's regular session. Apollomics's stock is trading at a volume of 85.4 million shares as of 13:30 EST. This is 162635.8% of its av
Genelux(GNLX.US) 10% Shareholder Sells US$110.64K in Common Stocks
$Genelux(GNLX.US)$ 10% Shareholder Szalay Aladar sold 5,704 shares of Common Stocks on Oct 25, 2023 at an average price of $19.3965 for a total value of $110.64K.Source: Announcement What is statement
Genelux Insider Sold Shares Worth $110,638, According to a Recent SEC Filing
Aladar Szalay, 10% Owner, on October 25, 2023, sold 5,704 shares in Genelux (GNLX) for $110,638. Following the Form 4 filing with the SEC, Szalay has control over a total of 4,185,305 shares of the co
Genelux Corporation 10% Owner Discloses Sale of 49,987 Shares